Laboratory-based Investigator

Search by job title or keywords Search by location

DANA-FARBER CANCER INSTITUTE

Dedicated to Discovery…Committed to Care Laboratory-based Investigator, Faculty Search The Department of Medical Oncology at the Dana-Farber Cancer Institute (DFCI) and the Brigham andWomen’s Hospital (BWH) is inviting applications for an academic, wet laboratory, investigator positionfocused on basic and translational approaches to cancer. An ideal candidate would be at the Instructorrank and have a successful past and planned future research program focused on: biology of red blood celldevelopment controlled by kinase signaling, mechanisms of anemia in the setting of chronic disease andmyelodysplastic syndromes, and pharmacologic targeting erythrocytosis in the setting ofmyeloproliferative neoplasms. The candidate must have an MD, PhD, or MD/PhD degree and a proventrack record of outstanding laboratory research in cancer. The successful candidate is expected to developand lead an independent laboratory and take an active role in the Department’s multidisciplinaryactivities, where multiple opportunities exist for collaboration with basic, translational, and clinicalresearchers. The position is based in both the Department of Medical Oncology at DFCI and the Department ofMedicine at the BWH and includes collaboration with other institutions affiliated with the Dana-Farber/Harvard Cancer Center and the Harvard Medical School. The investigator is expected to participate in Harvard University courses/workshops for students andfellows taught in the School of Medicine and supervise, teach and mentor postdoctoral fellows andgraduate students. The academic appointment will be at the Instructor level at Harvard Medical School and determined bythe applicant's credentials. Salary and benefits will be competitive with other institutions. Andrew A. Lane, MD, PhD Chair, Medical Oncology Search Committee Dana-Farber Cancer Institute 450 Brookline Avenue Boston, MA 02215 E-mail: View email address on click.appcast.io Application deadline: 9/21/2026 Dana-Farber Cancer Institute is an NCI-designated Comprehensive Cancer Center. We are an equalopportunity employer and all qualified applicants will receive consideration for employment withoutregard to race, color, religion, sex, national origin, disability status, protected veteran status, genderidentity, sexual orientation, pregnancy and pregnancy-related conditions or any other characteristicprotected by law. #J-18808-Ljbffr American Society of Hematology